Search

everythinglearnresearchcommunity

for

Search:↓

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

The document concludes that hair loss in women can be caused by various factors and is managed with specific treatments like medication, therapy, and lifestyle changes.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Longer CAG repeats in gene linked to more severe hair loss in females.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Blocking androgen receptors helps immune cells better fight certain bacteria.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Both estrogens and androgens are important for health in both males and females.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Androgens increase cervical cancer risk and affect its development.

Spironolactone may help treat excessive hair growth in girls, but more research is needed.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Gut bacteria can lower androgen levels in male mice.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Lowering testosterone speeds up wound healing in male mice.